<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Core Laboratories Nv — News on 6ix</title>
<link>https://6ix.com/company/core-laboratories-nv</link>
<description>Latest news and press releases for Core Laboratories Nv on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 21:15:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/core-laboratories-nv" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835562578dffbe2df0e99b6.webp</url>
<title>Core Laboratories Nv</title>
<link>https://6ix.com/company/core-laboratories-nv</link>
</image>
<item>
<title>CORE LAB REPORTS FIRST QUARTER 2026 RESULTS</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-first-quarter-2026-results</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-first-quarter-2026-results</guid>
<pubDate>Wed, 29 Apr 2026 21:15:00 GMT</pubDate>
<description>Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported first quarter 2026 revenue of $121,800,000. Core's operating income was $1,900,000, with a loss per diluted share of $0.02, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $6,600,000, yielding operating margins of over 5% and earnings per diluted share ("EPS"), ex-items, of $0.06. A full reconciliation of non-GAAP financ</description>
</item>
<item>
<title>CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-lab-announces-impact-of-the-middle-east-conflict-to-first-quarter-2026-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-lab-announces-impact-of-the-middle-east-conflict-to-first-quarter-2026-guidance</guid>
<pubDate>Mon, 23 Mar 2026 21:00:00 GMT</pubDate>
<description>Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") continues to evaluate and monitor the evolving geopolitical conflict in the Middle East and its effect on the Company's first quarter 2026 financial results. Core Lab is working with clients and its local teams to manage operations and mitigate impacts on project execution through a rapidly changing operating environment. The safety and security of the Company's employees remain its highest priority.</description>
</item>
<item>
<title>CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-fourth-quarter-221500197</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-fourth-quarter-221500197</guid>
<pubDate>Wed, 04 Feb 2026 22:15:00 GMT</pubDate>
<description>Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported fourth quarter 2025 revenue of $138,300,000. Core's operating income was $15,800,000, with earnings per diluted share ("EPS") of $0.15, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $15,700,000, yielding operating margins of over 11% and EPS, ex-items, of $0.21. For the full year 2025, revenue of $526,500,000 was up sl</description>
</item>
<item>
<title>CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-timing-fourth-210500990</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-timing-fourth-210500990</guid>
<pubDate>Mon, 05 Jan 2026 21:05:00 GMT</pubDate>
<description>Core Laboratories (NYSE: "CLB") will host its fourth quarter 2025 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on February 5, 2026.</description>
</item>
<item>
<title>CORE LAB REPORTS THIRD QUARTER 2025 RESULTS</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-third-quarter-210000036</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-third-quarter-210000036</guid>
<pubDate>Wed, 22 Oct 2025 21:00:00 GMT</pubDate>
<description>Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported third quarter 2025 revenue of $134,500,000. Core's operating income was $20,900,000, with earnings per diluted share ("EPS") of $0.30, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $16,600,000, yielding operating margins of 12%, sequential incremental margins of 48%, and EPS, ex-items, of $0.22. A full reconciliation o</description>
</item>
<item>
<title>CORE LABORATORIES ANNOUNCES STRATEGIC ACQUISITION OF BRAZIL-BASED SOLINTEC</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-strategic-acquisition-201500190</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-strategic-acquisition-201500190</guid>
<pubDate>Tue, 30 Sep 2025 20:15:00 GMT</pubDate>
<description>Core Laboratories (NYSE: "CLB") announced today the acquisition of Brazil-based integrated geological services company, Solintec.</description>
</item>
<item>
<title>CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-timing-third-203000621</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-timing-third-203000621</guid>
<pubDate>Wed, 24 Sep 2025 20:30:00 GMT</pubDate>
<description>Core Laboratories (NYSE: "CLB") will host its third quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on October 23, 2025.</description>
</item>
<item>
<title>CORE LAB REPORTS SECOND QUARTER 2025 RESULTS</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-second-quarter-211500436</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-second-quarter-211500436</guid>
<pubDate>Wed, 23 Jul 2025 21:15:00 GMT</pubDate>
<description>Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of $130,200,000. Core's operating income was $15,300,000, with earnings per diluted share ("EPS") of $0.22, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $14,500,000, yielding operating margins of 11%, sequential incremental margins of 41%, and EPS, ex-items, of $0.19. A full reconciliation</description>
</item>
<item>
<title>CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-timing-second-201500380</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-timing-second-201500380</guid>
<pubDate>Tue, 24 Jun 2025 20:15:00 GMT</pubDate>
<description>Core Laboratories (NYSE: "CLB") will host its second quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on July 24, 2025.</description>
</item>
<item>
<title>CORE LABORATORIES ANNOUNCES OPENING OF UNCONVENTIONAL CORE ANALYSIS LABORATORY IN SAUDI ARABIA</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-opening-unconventional-165300687</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-opening-unconventional-165300687</guid>
<pubDate>Wed, 07 May 2025 16:53:00 GMT</pubDate>
<description>Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia. This state-of-the-art facility, developed in collaboration with Core's long-time partner, Abdulla Fouad Group, underscores the Company's commitment to advancing reservoir evaluation technologies in the Middle East.</description>
</item>
<item>
<title>CORE LAB REPORTS FIRST QUARTER 2025 RESULTS</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-first-quarter-211500275</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-lab-reports-first-quarter-211500275</guid>
<pubDate>Wed, 23 Apr 2025 21:15:00 GMT</pubDate>
<description>Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,600,000. Core's operating income was $4,400,000, with earnings per diluted share ("EPS") of $0.00, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $11,800,000, yielding operating margins of 10%, and EPS, ex-items, of $0.14. During the first quarter of 2025, the Company recorded an adjus</description>
</item>
<item>
<title>CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL</title>
<link>https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-timing-first-201500783</link>
<guid isPermaLink="true">https://6ix.com/company/core-laboratories-nv/news/core-laboratories-announces-timing-first-201500783</guid>
<pubDate>Mon, 24 Mar 2025 20:15:00 GMT</pubDate>
<description>Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025.</description>
</item>
</channel>
</rss>